survorexant

Drugmaker Merck & Co. (NYSE: MRK) saw shares rise 2.5 percent in afternoon trading as it announced 8,500 job cuts and touted savings of $2.5 billion as part of a global initiative “to sharpen its commercial and research and development focus.” Merck CEO Kenneth C. Frazier said in a news...